Order Article Reprints

Neidler S, Kruspig B, Hewit K, Monteverde T, Gyuraszova K, Braun A, Clark W, James D, Hedley A, Nieswandt B, et al. Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma. Cancers. 2019; 11(5):600. https://doi.org/10.3390/cancers11050600

Neidler, Sarah, Björn Kruspig, Kay Hewit, Tiziana Monteverde, Katarina Gyuraszova, Attila Braun, William Clark, Daniel James, Ann Hedley, Bernhard Nieswandt, and et al. 2019. "Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma" Cancers 11, no. 5: 600. https://doi.org/10.3390/cancers11050600

Neidler, S., Kruspig, B., Hewit, K., Monteverde, T., Gyuraszova, K., Braun, A., Clark, W., James, D., Hedley, A., Nieswandt, B., Shanks, E., Dick, C., & Murphy, D. J. (2019). Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma. Cancers, 11(5), 600. https://doi.org/10.3390/cancers11050600